Skip to main content
  • Pulmonary Artery Denervation Improved Patient Outcomes at 6 Months: Sham-Controlled Trial Data

    Pulmonary artery denervation (PADN) improved exercise capacity, hemodynamics and clinical outcomes in patients with Group I pulmonary arterial hypertension (PAH) as classified by the World Health Organization (WHO), 6-month trial data report.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details